hydrochlorothiazide has been researched along with Nephrolithiasis in 4 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Nephrolithiasis: Formation of stones in the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nephrolithiasis is a global healthcare problem with a current lifetime risk of 18." | 6.87 | Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. ( Amico, P; Bedino, G; Bonny, O; Buchkremer, F; Del Giorno, R; Dhayat, NA; Ernandez, T; Faller, N; Fuster, DG; Gabutti, L; Hüsler, C; Irincheeva, I; Koneth, I; Mayr, M; Mohebbi, N; Odermatt, U; Pellegrini, L; Rintelen, F; Ritter, A; Roth, B; Roumet, M; Schönholzer, C; Stoermann-Chopard, C; Tamò, L; Teta, D; Trelle, S; Venzin, RM; Vogt, B, 2018) |
| "Nephrolithiasis is a global healthcare problem with a current lifetime risk of 18." | 2.87 | Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. ( Amico, P; Bedino, G; Bonny, O; Buchkremer, F; Del Giorno, R; Dhayat, NA; Ernandez, T; Faller, N; Fuster, DG; Gabutti, L; Hüsler, C; Irincheeva, I; Koneth, I; Mayr, M; Mohebbi, N; Odermatt, U; Pellegrini, L; Rintelen, F; Ritter, A; Roth, B; Roumet, M; Schönholzer, C; Stoermann-Chopard, C; Tamò, L; Teta, D; Trelle, S; Venzin, RM; Vogt, B, 2018) |
| " In this report, no significant correlations between dosage of hydrochlorothiazide and calciuria and no significant correlations between proteinuria and dosage of enalapril were detected." | 1.38 | The long-term use of enalapril and hydrochlorothiazide in two novel mutations patients with Dent's disease type 1. ( Henriques, Ldos S; Igarashi, T; Koch, VH; Seki, G; Sekine, T; Vaisbich, MH, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, L | 1 |
| Maalouf, NM | 1 |
| Dhayat, NA | 1 |
| Faller, N | 1 |
| Bonny, O | 1 |
| Mohebbi, N | 1 |
| Ritter, A | 1 |
| Pellegrini, L | 1 |
| Bedino, G | 1 |
| Schönholzer, C | 1 |
| Venzin, RM | 1 |
| Hüsler, C | 1 |
| Koneth, I | 1 |
| Del Giorno, R | 1 |
| Gabutti, L | 1 |
| Amico, P | 1 |
| Mayr, M | 1 |
| Odermatt, U | 1 |
| Buchkremer, F | 1 |
| Ernandez, T | 1 |
| Stoermann-Chopard, C | 1 |
| Teta, D | 1 |
| Rintelen, F | 1 |
| Roumet, M | 1 |
| Irincheeva, I | 1 |
| Trelle, S | 1 |
| Tamò, L | 1 |
| Roth, B | 1 |
| Vogt, B | 1 |
| Fuster, DG | 1 |
| Vaisbich, MH | 1 |
| Henriques, Ldos S | 1 |
| Igarashi, T | 1 |
| Sekine, T | 1 |
| Seki, G | 1 |
| Koch, VH | 1 |
| Arrabal-Polo, MA | 1 |
| Arias-Santiago, S | 1 |
| de Haro-Muñoz, T | 1 |
| Lopez-Ruiz, A | 1 |
| Orgaz-Molina, J | 1 |
| Gonzalez-Torres, S | 1 |
| Zuluaga-Gomez, A | 1 |
| Arrabal-Martin, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Double-blind Placebo-controlled Trial Assessing the Efficacy of Standard and Low Dose Hydrochlorothiazide Treatment in the Prevention of Recurrent Nephrolithiasis[NCT03057431] | Phase 3 | 416 participants (Actual) | Interventional | 2017-03-09 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for hydrochlorothiazide and Nephrolithiasis
| Article | Year |
|---|---|
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Topics: Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; | 2018 |
3 other studies available for hydrochlorothiazide and Nephrolithiasis
| Article | Year |
|---|---|
24-Hour Urine Calcium in the Evaluation and Management of Nephrolithiasis.
Topics: Adult; Calcium; Diuretics; Humans; Hydrochlorothiazide; Hypercalciuria; Male; Nephrolithiasis | 2017 |
The long-term use of enalapril and hydrochlorothiazide in two novel mutations patients with Dent's disease type 1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Enalapril; Genetic Diseases, X-Li | 2012 |
Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Fema | 2013 |